<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-vaccines-08-00098">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Villinger</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Rollin</surname>
    <given-names>P.E.</given-names>
   </name>
   <name>
    <surname>Brar</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Chikkala</surname>
    <given-names>N.F.</given-names>
   </name>
   <name>
    <surname>Winter</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sundstrom</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Zaki</surname>
    <given-names>S.R.</given-names>
   </name>
   <name>
    <surname>Swanepoel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ansari</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Peters</surname>
    <given-names>C.J.</given-names>
   </name>
  </person-group>
  <article-title>Markedly Elevated Levels of Interferon (IFN)-γ, IFN-α, Interleukin (IL)-2, IL-10, and Tumor Necrosis Factor-α Associated with Fatal Ebola Virus Infection</article-title>
  <source>J. Infect. Dis.</source>
  <year>1999</year>
  <volume>179</volume>
  <fpage>S188</fpage>
  <lpage>S191</lpage>
  <pub-id pub-id-type="doi">10.1086/514283</pub-id>
  <?supplied-pmid 9988183?>
  <pub-id pub-id-type="pmid">9988183</pub-id>
 </element-citation>
</ref>
